STAT3 and neoplasm: As stated above, IL-17 signaling triggered activation of STAT3 pathway and NF-κB pathway consequently promotes the release of a variety of proinflammatory factors and chemokines from tumor cells, which can contribute to maintain the proinflammatory reaction locally [59].